Latest news
Semaglutide generics regain momentum in July — but few brands lead the charge - ET PharmaET Pharma · Sat, 08 Aug 2026 11:29:18 GMTEli Lilly Launches Attacks On Tirzepatide Generics - Law360Law360 · Fri, 07 Aug 2026 20:01:00 GMTSBFM Stock Pops As Health Canada Greenlights New Generics - StocksToTradeStocksToTrade · Fri, 07 Aug 2026 13:17:00 GMTDutch Court Blocks Compounded Semaglutide, Confirming Europe's Generics Lockout Persists - Tech TimesTech Times · Thu, 06 Aug 2026 19:23:56 GMTPlan sponsors weigh GLP-1 generics amid supply, cost gaps - Benefits and Pensions MonitorBenefits and Pensions Monitor · Thu, 06 Aug 2026 18:12:20 GMTViatris Q2 preview: Analysts see profits softening amid pressure on generics business (VTRS:NASDAQ) - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 16:00:27 GMTSpecialty Generics Market Size To Exceed $295.53 Billion By 2035 - SNS InsiderSNS Insider · Mon, 03 Aug 2026 12:49:12 GMTSandoz ends remaining US antitrust claims to resolve legacy generic medicine litigation - The Pharma LetterThe Pharma Letter · Mon, 03 Aug 2026 10:11:01 GMT